SFN and lip and oral cavity carcinoma: Decreased expression levels of stratifin occur frequently in many human cancers including breast [26–33], lung [34], colon [35], liver [36], prostate [37–39], ovary [40–42], nasopharynx [43], and oral cancers [44].